$3.2m project targets aggressive MDM2 in breast cancer
A University of Houston scientist has joined a $3.2 million research collaboration to develop a new drug targeting one of the key drivers of triple-negative breast cancer.
UTHSC In the Media
Researchers Develop Novel Treatment Option for Triple Negative Breast Cancer
A researcher at the University of Houston College of Pharmacy has joined a $3.2 million effort to develop a promising new treatment for triple-negative breast cancer (TNBC), one of the most aggressive and difficult-to-treat forms of the disease, accounting for 10-15% of all breast cancer cases.
UH Researcher Part of $3.2M Initiative to Develop Innovative Breast Cancer Therapy
A groundbreaking development in the treatment of triple-negative breast cancer (TNBC) is emerging from a collaborative research initiative involving the University of Houston and the University of Tennessee Health Science Center.
UH Researcher Part of $3.2M Initiative to Develop Innovative Breast Cancer Therapy
A groundbreaking development in the treatment of triple-negative breast cancer (TNBC) is emerging from a collaborative research initiative involving the University of Houston and the University of Tennessee Health Science Center.
UH researcher joins $3.2 million effort to develop promising new breast cancer treatment
Research targets deadly triple-negative breast cancer
Maury Regional Health Care Foundation Announces 2026 Board Appointments
The Maury Regional Health Care Foundation announced appointments to its board of directors for 2026 during the group’s December meeting.
AI-powered liquid biopsy can classify pediatric brain tumors with 92% accuracy
Liquid biopsies, which test body fluids that contain cancerous material, including circulating tumor DNA (ctDNA), are a noninvasive way to learn about a cancer’s biology.
Classifying pediatric brain tumors by liquid biopsy using artificial intelligence
Liquid biopsies, which test body fluids that contain cancerous material, including circulating tumor DNA (ctDNA), are a noninvasive way to learn about a cancer’s biology.